Literature DB >> 28597971

Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia.

Azumi Sakakibara1, Yukiko Hashimoto1, Rie Kawakita1, Yuki Hosokawa1, Keiko Nagahara2, Yukihiro Hasegawa2, Shin Hoshino3, Hironori Nagasaka4, Tohru Yorifuji1.   

Abstract

OBJECTIVES: To define the ranges of biochemical markers during hypoglycemia for the diagnosis of congenital hyperinsulinism (CHI), using high sensitivity insulin assays.
SUBJECTS: A total of 298 patients with CHI and 58 control patients with non-hyperinsulinemic hypoglycemia, who were diagnosed after 2007.
METHODS: The levels of biochemical markers (glucose, insulin, β-hydroxybutyrate [BHB], free fatty acids [FFA], lactate, ammonia) at the time of hypoglycemia were analyzed along with the maximal glucose infusion rate (GIR) to maintain euglycemia and clinical outcomes.
RESULTS: Median levels of blood glucose in patients with CHI and in controls were 30 and 46 mg/dL, while insulin levels were 9.90 and undetectable (<.5) μU/mL, respectively. Similarly, median levels of BHB were 17.5 and 3745 µmol/L, and those of FFA were 270.5 and 2660 µmol/L, respectively. For patients after 5 months, cutoffs of insulin >1.25 μU/mL, BHB < 2000 µmol/L, and FFA < 1248 µmol/L predicted CHI with sensitivities of 97.5, 96.2, and 95.2% and specificities of 84.2, 89.3, and 92.3%, respectively. Maximal GIR in the CHI groups tended to decrease with age. In addition, decreased gestational age, low birth weight, and elevated lactate at hypoglycemia were significantly more common in patients who were off treatment within 100 days without pancreatectomy.
CONCLUSIONS: After introduction of high-sensitive assays, the diagnostic value of insulin was improved, allowing for more efficient cutoffs to be set for diagnosis of CHI. Premature birth, low birth weight and elevated lactate might be helpful in predicting early remission of hypoglycemia.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis; hyperinsulinism; hypoglycemia; insulin

Mesh:

Substances:

Year:  2017        PMID: 28597971     DOI: 10.1111/pedi.12548

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  3 in total

1.  Longitudinal Auxological recovery in a cohort of children with Hyperinsulinaemic Hypoglycaemia.

Authors:  Chris Worth; Laila Al Hashmi; Daphne Yau; Maria Salomon-Estebanez; Diego Perez Ruiz; Caroline Hall; Elaine O'Shea; Helen Stokes; Peter Foster; Sarah E Flanagan; Karen E Cosgrove; Mark J Dunne; Indraneel Banerjee
Journal:  Orphanet J Rare Dis       Date:  2020-06-24       Impact factor: 4.123

2.  Altered Serum Amino Acid and Acylcarnitine Profiles in Hyperinsulinemic Hypoglycemia and Ketotic Hypoglycemia.

Authors:  Zhen-Ran Xu; Xiao-Yi Zhu; Wei Lu; Wei-Hua Sun; Ruo-Qian Cheng; Jin-Wen Ni; Li Xi; Khalid Hussain; Fei-Hong Luo; Miao-Ying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-08       Impact factor: 5.555

3.  Analysis on the pathogenic genes of 60 Chinese children with congenital hyperinsulinemia.

Authors:  Zi-Di Xu; Wei Zhang; Min Liu; Huan-Min Wang; Pei-Pei Hui; Xue-Jun Liang; Jie Yan; Yu-Jun Wu; Yan-Mei Sang; Cheng Zhu; Gui-Chen Ni
Journal:  Endocr Connect       Date:  2018-11-12       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.